Literature DB >> 20359463

Involvement of natural killer T cells in halothane-induced liver injury in mice.

Linling Cheng1, Qiang You, Hao Yin, Michael P Holt, Cynthia Ju.   

Abstract

Drug-induced liver injury (DILI) causes significant patient morbidity and mortality, and is the most common reason for drug withdrawals. It is imperative to gain a thorough understanding of the underlying mechanisms of DILI to effectively predict and prevent these reactions. We have recently developed a murine model of halothane-induced liver injury (HILI). The aim of the present study was to investigate the role of hepatic natural killer T (NKT) cells in the pathogenesis of HILI. The degrees of HILI were compared between WT and CD1d(-/-) mice, which are deficient in NKT cells. The data revealed that CD1d(-/-) mice were resistant in developing HILI. This resistance appeared to be a direct result of NKT cell depletion rather than an indirect one due to the absence of cross-talk between NKT cells and other hepatic innate immune cells. Compared with WT mice, CD1d(-/-) mice exhibited a significantly lower number of hepatic infiltrating neutrophils upon halothane challenge (470,000+/-100,000/liver in WT vs. 120,000+/-31,500/liver in CD1d(-/-) mice). This result in conjunction with our previous finding of an indispensable role of neutrophils in HILI strongly suggests that NKT cells play a critical role in regulating neutrophil recruitment, thereby contributing to the development of HILI. Collectively, the current study and published reports indicate that this murine model of HILI provides an experimental system for the investigation of the underlying mechanisms of DILI. In addition, this model may yield the discovery of susceptibility factors that may control the development of liver injury in patients treated with halothane and potentially other drugs. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359463      PMCID: PMC2888538          DOI: 10.1016/j.bcp.2010.03.025

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  34 in total

Review 1.  NKT cells: facts, functions and fallacies.

Authors:  D I Godfrey; K J Hammond; L D Poulton; M J Smyth; A G Baxter
Journal:  Immunol Today       Date:  2000-11

2.  Safety of newly approved drugs: implications for prescribing.

Authors:  Robert J Temple; Martin H Himmel
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

3.  Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

Authors:  George Ostapowicz; Robert J Fontana; Frank V Schiødt; Anne Larson; Timothy J Davern; Steven H B Han; Timothy M McCashland; A Obaid Shakil; J Eileen Hay; Linda Hynan; Jeffrey S Crippin; Andres T Blei; Grace Samuel; Joan Reisch; William M Lee
Journal:  Ann Intern Med       Date:  2002-12-17       Impact factor: 25.391

4.  Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases.

Authors:  Hongyan Diao; Shigeyuki Kon; Kazuya Iwabuchi; Chiemi Kimura; Junko Morimoto; Daisuke Ito; Tatsuya Segawa; Masahiro Maeda; Junji Hamuro; Toshinori Nakayama; Masaru Taniguchi; Hideo Yagita; Luc Van Kaer; Kazunori Onóe; David Denhardt; Susan Rittling; Toshimitsu Uede
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

5.  Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency.

Authors:  Aleksandar K Stanic; A Dharshan De Silva; Jang-June Park; Venkataraman Sriram; Shinichi Ichikawa; Yoshio Hirabyashi; Kyoko Hayakawa; Luc Van Kaer; Randy R Brutkiewicz; Sebastian Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

6.  Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment.

Authors:  Matthew J Ruddy; Fang Shen; Jeffrey B Smith; Ashu Sharma; Sarah L Gaffen
Journal:  J Leukoc Biol       Date:  2004-04-23       Impact factor: 4.962

7.  Effects of N-acetylcysteine and dithiothreitol on glutathione and protein thiol replenishment during acetaminophen-induced toxicity in isolated mouse hepatocytes.

Authors:  E Rafeiro; S G Barr; J J Harrison; W J Racz
Journal:  Toxicology       Date:  1994-11-11       Impact factor: 4.221

8.  Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.

Authors:  H Sakai; T Okamoto; Y Kikkawa
Journal:  J Pharmacol Exp Ther       Date:  1992-10       Impact factor: 4.030

9.  Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction.

Authors:  F Dieli; G Sireci; D Russo; M Taniguchi; J Ivanyi; C Fernandez; M Troye-Blomberg; G De Leo; A Salerno
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.

Authors:  H Mizuhara; E O'Neill; N Seki; T Ogawa; C Kusunoki; K Otsuka; S Satoh; M Niwa; H Senoh; H Fujiwara
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  16 in total

1.  Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration.

Authors:  Stephanie Mathews; Dechun Feng; Igor Maricic; Cynthia Ju; Vipin Kumar; Bin Gao
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

2.  Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Lynette S Chea; Jeffrey C Morrison; Julia D Berkson; Kenrick Semple; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2013-03-15       Impact factor: 17.425

3.  Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis.

Authors:  Christine M Dugan; Aaron M Fullerton; Robert A Roth; Patricia E Ganey
Journal:  Toxicol Sci       Date:  2011-01-18       Impact factor: 4.849

Review 4.  Managing the challenge of chemically reactive metabolites in drug development.

Authors:  B Kevin Park; Alan Boobis; Stephen Clarke; Chris E P Goldring; David Jones; J Gerry Kenna; Craig Lambert; Hugh G Laverty; Dean J Naisbitt; Sidney Nelson; Deborah A Nicoll-Griffith; R Scott Obach; Philip Routledge; Dennis A Smith; Donald J Tweedie; Nico Vermeulen; Dominic P Williams; Ian D Wilson; Thomas A Baillie
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

5.  Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Aaron M Fullerton; Midhun C Korrapati; Pauline M Ryan; Kenrick Semple; Jeffrey C Morrison; Julia D Berkson; Lynette S Chea; Qian Yang; Albert P Li; Rosanne Spolski; Erin E West; Yrina Rochman; Warren J Leonard; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2014-05-20       Impact factor: 17.425

6.  Halothane-induced hepatitis: paradigm or paradox for drug-induced liver injury.

Authors:  Mark J Kurth; Tsuyoshi Yokoi; M Eric Gershwin
Journal:  Hepatology       Date:  2014-09-25       Impact factor: 17.425

7.  Activation of natural killer T cells contributes to triptolide-induced liver injury in mice.

Authors:  Xin-Zhi Wang; Ru-Feng Xue; Shen-Ye Zhang; Ya-Ting Zheng; Lu-Yong Zhang; Zhen-Zhou Jiang
Journal:  Acta Pharmacol Sin       Date:  2018-07-16       Impact factor: 6.150

8.  19-substituted benzoquinone ansamycin heat shock protein-90 inhibitors: biological activity and decreased off-target toxicity.

Authors:  Chuan-Hsin Chang; Derek A Drechsel; Russell R A Kitson; David Siegel; Qiang You; Donald S Backos; Cynthia Ju; Christopher J Moody; David Ross
Journal:  Mol Pharmacol       Date:  2014-03-28       Impact factor: 4.436

Review 9.  Idiosyncratic adverse drug reactions: current concepts.

Authors:  Jack Uetrecht; Dean J Naisbitt
Journal:  Pharmacol Rev       Date:  2013-03-08       Impact factor: 25.468

Review 10.  The endoplasmic reticulum participated in drug metabolic toxicity.

Authors:  Qingcai Huang; Youwen Chen; Zhengjia Zhang; Zeyu Xue; Zhenglai Hua; Xinyi Luo; Yang Li; Cheng Lu; Aiping Lu; Yuanyan Liu
Journal:  Cell Biol Toxicol       Date:  2022-01-18       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.